{
    "Trade/Device Name(s)": [
        "MicroScan\u00ae Dried Gram Negative MIC/Combo Panels",
        "MicroScan\u00ae Dried Gram Negative Panel"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K061687",
    "Predicate Device Reference 510(k) Number(s)": [
        "K020037"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY",
        "LRG"
    ],
    "Summary Letter Date": "June 14, 2006",
    "Summary Letter Received Date": "June 15, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Extended-Spectrum Beta-Lactamase (ESBL)",
        "Escherichia coli",
        "Klebsiella oxytoca",
        "Klebsiella pneumoniae",
        "Proteus mirabilis"
    ],
    "Specimen Type(s)": [
        "Gram Negative organisms"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan\u00ae instrumentation",
        "WalkAway\u00ae",
        "autoSCAN\u00ae"
    ],
    "Method(s)/Technology(ies)": [
        "Microdilution",
        "Antimicrobial susceptibility testing",
        "Automated and manual read methods"
    ],
    "Methodologies": [
        "MIC determination",
        "ESBL confirmation"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan\u00ae Dried Gram Negative MIC/Combo Panels for ESBL confirmation in select Gram negative organisms using cefotaxime, ceftazidime, and clavulanic acid.",
    "Indications for Use Summary": "Designed to confirm Extended-Spectrum Beta-Lactamase production in Escherichia coli, Klebsiella spp., and Proteus mirabilis via MIC/Combo panel using cefotaxime, ceftazidime, and clavulanic acid with visual or automated read methods.",
    "fda_folder": "Microbiology"
}